On April 22, 2025, Chemours Co held its annual shareholder meeting, where all twelve director nominees were elected, executive compensation was approved (93.8% in favor), and the selection of their accounting firm was ratified (98.9% in favor), while proposals to change voting provisions and assess biodiversity impacts were not approved.